John M Maris
University of Pennsylvania
H-index: 118
North America-United States
Top articles of John M Maris
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Post-GWAS Functional Analysis of the 11p11.2 Risk Locus Identifies HSD17B12 as a Neuroblastoma Susceptibility Gene Involved in Lipid Metabolism | Proceedings | Teresa Maiorino Marianna Avitabile Vito Alessandro Lasorsa Annalaura Montella Sueva Cantalupo | 2024/3/27 |
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I‐MIBG in patients with relapsed/refractory … | Pediatric Blood & Cancer | Vandana Batra Ajami Gikandi Bruce Pawel Daniel Martinez M Meaghan Granger | 2024/1 |
Surface and global proteome analyses identify ENPP1 and other surface proteins as actionable immunotherapeutic targets in Ewing sarcoma | Clinical Cancer Research | Brian Mooney Gian Luca Negri Taras Shyp Alberto Delaidelli Hai-Feng Zhang | 2024/3/1 |
ALK upregulates POSTN and WNT signaling to drive neuroblastoma | Cell Reports | Miller Huang Wanqi Fang Alvin Farrel Linwei Li Antonios Chronopoulos | 2024/3/26 |
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival | JNCI: Journal of the National Cancer Institute | Jung Kim Zalman Vaksman Laura E Egolf Rebecca Kaufman J Perry Evans | 2024/1/1 |
Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single‐center retrospective study | Pediatric Blood & Cancer | Sean Schoeman Rochelle Bagatell Anne Marie Cahill John Maris Peter Mattei | 2024/1/30 |
Next-generation immunocompetent and humanized neuroblastoma murine models for the discovery and validation of novel immunotherapies | Cancer Research | Timothy T Spear Elisabeth Posthill David Groff Anna M Giudice Kristopher R Bosse | 2024/3/22 |
Abstract LB402: In vivo efficacy of anti-B7-H3 antibody-drug conjugate (ADC) ifinatamab deruxtecan (I-DXd; DS-7300): An update from the Pediatric Preclinical In Vivo Testing … | Cancer Research | Richard Gorlick Jonathan Gill Wendong Zhang Yael Mosse John Maris | 2024/4/5 |
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma | JNCI: Journal of the National Cancer Institute | Michael P Randall Laura E Egolf Zalman Vaksman Minu Samanta Matthew Tsang | 2024/1/1 |
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial | The Lancet Diabetes & Endocrinology | Parminder K Judge Natalie Staplin Kaitlin J Mayne Christoph Wanner Jennifer B Green | 2024/1/1 |
Targeting DLK1, a Notch ligand, with an antibody-drug conjugate in adrenocortical carcinoma | Cancer Research | Nai-Yun Sun Suresh Kumar Amber Weiner Yoo Sun Kim Arnulfo Mendoza | 2024/3/22 |
The Virtual Child | Cancer Discovery | Richard J Gilbertson Sam Behjati Anna-Lisa Böttcher Marianne E Bronner Matthew Burridge | 2024/4/4 |
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial | The Lancet Diabetes & Endocrinology | N Staplin R Haynes PK Judge C Wanner JB Green | 2024/1/1 |
GPC2 directed CAR T cells are efficacious against fusion-positive and fusion-negative rhabdomyosarcomas | Cancer Research | Rawan Shraim Patrick M Schuerch Anna Maria Giudice Karina L Conkrite Amber K Weiner | 2024/3/22 |
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers | Andras Heczey David Steffin Nisha Ghatwai Antonino Montalbano Purva Rathi | 2024/4/3 | |
BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular states | bioRxiv | Irene Felipe Jaime Martinez de Villarreal Khushbu Patel Jorge L Martinez-Torrecuadrada Liron D Grossmann | 2024 |
Glypican 2 as a cancer marker and therapeutic target | 2023/11/14 | ||
Targeting of intracellular oncoproteins with peptide-centric CARs | Nature | Mark Yarmarkovich Quinlen F Marshall John M Warrington Rasika Premaratne Alvin Farrel | 2023/11/23 |
ALCAM promotes neuroblastoma proliferation, migration, and immune evasion | Cancer Research | Jarrett Lindsay Minu Samanta Nathan Kendsersky Jonathan Gaither Molly Christie | 2023/4/4 |
Dr Audrey E. Evans (1925–2022): academic trailblazer par excellence | Pediatric Research | Max J Coppes John M Maris | 2023/6 |
Co-Authors
